NCT05012761View on ClinicalTrials.gov

The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 24, 2021

Primary Completion Date

December 27, 2021

Study Completion Date

May 27, 2022

Conditions
Healthy
Interventions
DRUG

SR419 capsules

Ascending single and multiple doses of SR419 orally

DRUG

Placebo

Ascending single and multiple doses of placebo orally

Trial Locations (1)

Unknown

Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU), Shanghai

All Listed Sponsors
lead

Shanghai SIMR Biotechnology Co., Ltd.

INDUSTRY

NCT05012761 - The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers | Biotech Hunter | Biotech Hunter